US Bancorp DE decreased its position in shares of Aetna Inc. (NYSE:AET) by 9.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 101,783 shares of the company’s stock after selling 10,064 shares during the period. US Bancorp DE’s holdings in Aetna were worth $11,752,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Parkside Financial Bank & Trust increased its stake in shares of Aetna by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 829 shares of the company’s stock worth $101,000 after buying an additional 73 shares during the last quarter. Hartford Financial Management Inc. increased its stake in shares of Aetna by 304.8% in the second quarter. Hartford Financial Management Inc. now owns 850 shares of the company’s stock worth $101,000 after buying an additional 640 shares during the last quarter. Ledyard National Bank increased its stake in shares of Aetna by 14.4% in the third quarter. Ledyard National Bank now owns 876 shares of the company’s stock worth $101,000 after buying an additional 110 shares during the last quarter. FTB Advisors Inc. increased its stake in shares of Aetna by 0.7% in the third quarter. FTB Advisors Inc. now owns 880 shares of the company’s stock worth $101,000 after buying an additional 6 shares during the last quarter. Finally, Acrospire Investment Management LLC increased its stake in shares of Aetna by 37.3% in the second quarter. Acrospire Investment Management LLC now owns 1,105 shares of the company’s stock worth $135,000 after buying an additional 300 shares during the last quarter. 88.28% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Shares of Aetna Inc. (NYSE:AET) traded up 2.31% during mid-day trading on Tuesday, reaching $131.35. The company’s stock had a trading volume of 1,580,393 shares. The company’s 50 day moving average price is $115.34 and its 200-day moving average price is $116.60. Aetna Inc. has a 1-year low of $92.42 and a 1-year high of $132.57. The company has a market capitalization of $46.09 billion, a price-to-earnings ratio of 18.94 and a beta of 0.54.

Aetna (NYSE:AET) last announced its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.02 by $0.05. The firm earned $15.78 billion during the quarter, compared to analysts’ expectations of $15.71 billion. Aetna had a return on equity of 16.25% and a net margin of 3.91%. The business’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.90 EPS. Analysts predict that Aetna Inc. will post $8.02 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The correct version of this report can be read at https://www.thecerbatgem.com/2016/11/29/us-bancorp-de-sells-10064-shares-of-aetna-inc-aet.html.

A number of research firms have commented on AET. Credit Suisse Group AG reiterated a “hold” rating and issued a $120.00 price target on shares of Aetna in a research note on Wednesday, August 3rd. Leerink Swann reiterated a “buy” rating and issued a $135.00 price target on shares of Aetna in a research note on Thursday, August 4th. FBR & Co reiterated a “hold” rating and issued a $135.00 price target on shares of Aetna in a research note on Thursday, August 4th. Jefferies Group reiterated a “hold” rating on shares of Aetna in a research note on Tuesday, September 6th. Finally, Barclays PLC reiterated a “buy” rating and issued a $142.00 price target on shares of Aetna in a research note on Monday, November 7th. Seven equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Aetna has a consensus rating of “Buy” and an average target price of $132.14.

In related news, Director Jeffrey E. Garten sold 7,100 shares of the company’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.90% of the stock is owned by corporate insiders.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.